Evaluation of intranasal nafamostat or camostat for SARS-CoV-2 chemoprophylaxis in Syrian golden hamsters
M. Neary, H. Box, J. Sharp, L. Tatham, P. Curley, J. Herriott, E. Kijak, U. Arshad, J. J. Hobson, R. K. Rajoli, H. Pertinez, A. Valentijn, K. Dhaliwal, F. McCaughan, S. P. Rannard, , A. Owen
This study evaluates intranasal nafamostat and camostat for preventing SARS-CoV-2 infection in Syrian golden hamsters, finding nafamostat effective in keeping viral RNA undetectable for 7 days.
bioRxiv · Jul 8, 2021 · PreprintPharmacology & Toxicology